Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Breast Neoplasms and MCL1[original query] |
---|
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget 2014 May 5 (9): 2349-54. Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda, Kurzrock Razel |
Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Aug 35 (8): 8289-99. Wang Sheng, Jiang Yan, Liu Jin, Zhao Yuanyuan, Xiang Chan, Ma Rong, Gao Haidong, Jin Li, He Fuchu, Wang Haiji |
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers. NPJ breast cancer 2018 4 19. Yap Yoon-Sim, Singh Angad P, Lim John H C, Ahn Jin-Hee, Jung Kyung-Hae, Kim Jeongeun, Dent Rebecca A, Ng Raymond C H, Kim Sung-Bae, Chiang Derek |
The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes. Cancers 2021 10 13 (20): . Martínez-Gregorio Héctor, Rojas-Jiménez Ernesto, Mejía-Gómez Javier César, Díaz-Velásquez Clara, Quezada-Urban Rosalía, Vallejo-Lecuona Fernando, de la Cruz-Montoya Aldo, Porras-Reyes Fany Iris, Pérez-Sánchez Víctor Manuel, Maldonado-Martínez Héctor Aquiles, Robles-Estrada Maybelline, Bargalló-Rocha Enrique, Cabrera-Galeana Paula, Ramos-Ramírez Maritza, Chirino Yolanda Irasema, Alonso Herrera Luis, Terrazas Luis Ignacio, Frecha Cecilia, Oliver Javier, Perdomo Sandra, Vaca-Paniagua Feli |
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer. Cancers 2021 10 13 (19): . Harbeck Nadia, von Schumann Raquel, Kates Ronald Ernest, Braun Michael, Kuemmel Sherko, Schumacher Claudia, Potenberg Jochem, Malter Wolfram, Augustin Doris, Aktas Bahriye, Forstbauer Helmut, Tio Joke, Grischke Eva-Maria, Biehl Claudia, Liedtke Cornelia, De Haas Sanne Lysbet, Deurloo Regula, Wuerstlein Rachel, Kreipe Hans Heinrich, Gluz Ol |
Somatic Mutations Alter Interleukin Signaling Pathways in Grade II Invasive Breast Cancer Patients: An Egyptian Experience. Current issues in molecular biology 2022 12 44 (12): 5890-5901. Nassar Auhood, Zekri Abdel Rahman N, Elberry Mostafa H, Lymona Ahmed M, Lotfy Mai M, Abouelhoda Mohamed, Youssef Amira Salah El-D |
Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. JAMA network open 2023 3 6 (3): e233329. Zhao Fangyuan, Miyashita Minoru, Hattori Masaya, Yoshimatsu Toshio, Howard Frederick, Kaneva Kristiyana, Jones Ryan, Bell Joshua S K, Fleming Gini F, Jaskowiak Nora, Nanda Rita, Zheng Yonglan, Huo Dezheng, Olopade Olufunmilayo |
Bilateral and synchronous male breast cancer: a case report. International journal of clinical and experimental pathology 2023 12 16 (11): 352-356. Shaoqiang Zhou, Jiankui Wang, Ming Li, Yinju Yang, Hushan Zhang, Dedian Ch |
- Page last reviewed:Feb 1, 2024
- Content source: